Correlation Between the International Consensus Definition of the Cancer Anorexia-Cachexia Syndrome (CACS) and Patient-Centered Outcomes in Advanced Non-Small Cell Lung Cancer

被引:51
作者
LeBlanc, Thomas W. [1 ,2 ,3 ]
Nipp, Ryan D. [5 ]
Rushing, Christel N. [2 ]
Samsa, Greg P. [2 ]
Locke, Susan C. [2 ]
Kamal, Arif H. [1 ,2 ,4 ]
Cella, David F. [6 ]
Abernethy, Amy P. [1 ,2 ,4 ]
机构
[1] Duke Univ, Sch Med, Duke Canc Inst, Durham, NC USA
[2] Duke Clin Res Inst, Ctr Learning Hlth, Durham, NC USA
[3] Duke Univ, Sch Med, Dept Med, Div Hematol Malignancies & Cellular Therapy, Durham, NC 27706 USA
[4] Duke Univ, Sch Med, Dept Med, Div Med Oncol, Durham, NC 27706 USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA
关键词
Patient outcome assessment; health services research; carcinoma; non-small cell lung; QUALITY-OF-LIFE; FUNCTIONAL ASSESSMENT; DOUBLE-BLIND; WEIGHT-LOSS; MISSING DATA; THERAPY; SYMPTOMS; TOXICITY; INFLAMMATION; SARCOPENIA;
D O I
10.1016/j.jpainsymman.2014.09.008
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Context. The cancer anorexia-cachexia syndrome (CACS) is common in patients with advanced solid tumors and is associated with adverse outcomes including poor quality of life (QOL), impaired functioning, and shortened survival. Objectives. To apply the recently posed weight-based international consensus CACS definition to a population of patients with advanced non-small cell lung cancer (NSCLC) and explore its impact on patient-reported outcomes. Methods. Ninety-nine patients participated in up to four study visits over a six-month period. Longitudinal assessments included measures of physical function, QOL, and other clinical variables such as weight and survival. Results. Patients meeting the consensus CACS criteria at Visit 1 had a significantly shorter median survival (239.5 vs. 446 days; hazard ratio, 2.06, P < 0.05). Physical function was worse in the CACS group (mean Karnofsky Performance Status score 68 vs. 77, Eastern Cooperative Oncology Group Performance Status score 1.8 vs. 1.3, P < 0.05 for both), as was QOL (Functional Assessment of Cancer Therapy-General [FACT-G] Lung Cancer subscale of 17.2 vs. 19.9, Anorexia/Cachexia subscale of 31.4 vs. 37.9, P < 0.05 for both). Differences in the FACT-G and the Functional Assessment of Chronic Illness Therapy-Fatigue subscale approached but did not reach statistical significance. Longitudinally, all measures of physical function and QOL worsened regardless of CACS status, but the rate of decline was more rapid in the CACS group. Conclusion. The weight-based component of the recently proposed international consensus CACS definition is useful in identifying patients with advanced NSCLC who are likely to have significantly inferior survival and who will develop more precipitous declines in physical function and QOL. This definition may be useful for clinical screening purposes and identify patients with high palliative care needs. (C) 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:680 / 689
页数:10
相关论文
共 50 条
[1]   Improving Health Care Efficiency and Quality Using Tablet Personal Computers to Collect Research-Quality, Patient-Reported Data [J].
Abernethy, Amy P. ;
Herndon, James E., II ;
Wheeler, Jane L. ;
Patwardhan, Meenal ;
Shaw, Heather ;
Lyerly, H. Kim ;
Weinfurt, Kevin .
HEALTH SERVICES RESEARCH, 2008, 43 (06) :1975-1991
[2]   Validation of the Patient Care Monitor (Version 2.0): A Review of System Assessment Instrument for Cancer Patients [J].
Abernethy, Amy P. ;
Zafar, Syed Yousuf ;
Uronis, Hope ;
Wheeler, Jane L. ;
Coan, April ;
Rowe, Krista ;
Shelby, Rebecca A. ;
Fowler, Robin ;
Herndon, James E., II .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2010, 40 (04) :545-558
[3]   Feasibility and Acceptability to Patients of a Longitudinal System for Evaluating Cancer-Related Symptoms and Quality of Life: Pilot Study of an e/Tablet Data-Collection System in Academic Oncology [J].
Abernethy, Amy P. ;
Herndon, James E. ;
Wheeler, Jane L. ;
Day, Jeannette M. ;
Hood, Linda ;
Patwardhan, Meenal ;
Shaw, Heather ;
Lyerly, Herbert Kim .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2009, 37 (06) :1027-1038
[4]   Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma [J].
Antoun, S. ;
Baracos, V. E. ;
Birdsell, L. ;
Escudier, B. ;
Sawyer, M. B. .
ANNALS OF ONCOLOGY, 2010, 21 (08) :1594-1598
[5]  
Argilés JM, 2001, MED RES REV, V21, P83, DOI 10.1002/1098-1128(200101)21:1<83::AID-MED4>3.0.CO
[6]  
2-1
[7]   Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis [J].
Baracos, Vickie E. ;
Reiman, Tony ;
Mourtzakis, Marina ;
Gioulbasanis, Ioannis ;
Antoun, Sami .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2010, 91 (04) :1133S-1137S
[8]   Cancer cachexia: It's time for more clinical trials [J].
Bossola, Maurizio ;
Pacelli, Fabio ;
Tortorelli, Antonio ;
Doglietto, Giovan Battista .
ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) :276-285
[9]  
Brooks D, 2003, AM J RESP CRIT CARE, V167, P1287, DOI 10.1164/ajrccm.167.9.950
[10]   General population and cancer patient norms for the functional assessment of cancer therapy-general (FACT-G) [J].
Brucker, PS ;
Yost, K ;
Cashy, J ;
Webster, K ;
Cella, D .
EVALUATION & THE HEALTH PROFESSIONS, 2005, 28 (02) :192-211